Data Material
ALK Medical Affairs Canada provides the resources found on this website for Canadian healthcare professionals only.
Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
Journal Publication
Click to view
By clicking here, you agree to visiting a site maintained by a third party, who is solely responsible for its contents.
Short Summary: Efficacy and safety of the ragweed SLIT-tablet in Canadian children/adolescents with ragweed pollen-induced AR/C was consistent with the total study population.